Uranium exploration company Jaguar Uranium (JAGU.US) plans to price its IPO at $4-6 and aims to raise $20 million.
Jaguar Uranium, a uranium exploration company, has confirmed the terms of its $20 million initial public offering in the United States.
Headquartered in Toronto, Canada, Jaguar Uranium (JAGU.US) is a company developing uranium mining exploration projects in Colombia and Argentina. The company announced the terms of its initial public offering (IPO) last Friday. The company plans to raise $20 million by issuing 4 million shares of stock at a price range of $4 to $6 per share. At the midpoint of the price range, Jaguar Uranium's market value will reach $82 million.
Jaguar Uranium is a Canadian-based junior mining company that is currently not profitable, focusing on three uranium exploration projects: one in Colombia and two in Argentina. Its main exploration project is the Berlin project in Caldas Province, Colombia, which is a sedimentary deposit containing uranium as well as vanadium, nickel, phosphate, rare earth elements, molybdenum, and zinc, located about 12 kilometers from a hydroelectric plant and about 65 kilometers from a river port leading to the Caribbean coast. In Argentina, the company is advancing the Laguna project in Chubut Province and the Huemul project in Mendoza Province.
Established in 2022, Jaguar Uranium plans to list on the NYSE American stock exchange with the stock symbol JAGU. Titan Partners is the sole book-running manager for this transaction.
Related Articles

On January 16, BEKE-W (02423) spent $3.5 million to repurchase 603,500 shares.

New stock news | Qinhao Pharmaceuticals submits application to Hong Kong Stock Exchange, mainly focusing on developing potential best-in-class targeted therapies in the field of oncology.
.png)
New Stock Update | Moganshan Home Delivery Form to Hong Kong Stock Exchange, serving as China's third largest green artificial board service provider.
On January 16, BEKE-W (02423) spent $3.5 million to repurchase 603,500 shares.

New stock news | Qinhao Pharmaceuticals submits application to Hong Kong Stock Exchange, mainly focusing on developing potential best-in-class targeted therapies in the field of oncology.

New Stock Update | Moganshan Home Delivery Form to Hong Kong Stock Exchange, serving as China's third largest green artificial board service provider.
.png)





